Chen et al 31 used chicken breasts as a proxy for human cervical tissue and found a mean depth of necrosis of 3.75 mm after thermoablation with the Liger device at 100°C for 20 seconds, yet the mean ...
The human papillomavirus test (HPV) test could improve the (cost−) effectiveness of cervical screening by selecting women with a very low risk for cervical cancer during a long period. An analysis of ...
(HealthDay)—Following introduction of human papillomavirus (HPV) vaccination in England, there was a substantial reduction in cervical cancer and the incidence of grade 3 cervical intraepithelial ...
It has been shown in 1996 by Fukasawa et al. (1) that in mouse cells lacking the p53 tumor suppressor protein numeric centrosome aberration occurs during the cell cycle. Loss of p53 may cause genetic ...
HPV, human papillomavirus Use of primary HPV testing results in significantly lower odds of CIN3 compared with cytology testing HealthDay News — The use of primary human papillomavirus (HPV) testing ...
Both complete and incomplete vaccination in individuals were associated with a significantly lower detection rate of high-risk HPV 16/18 and 16/18/31/33/45 in CIN2 compared with no vaccination.
A potential new immune-based therapy to treat precancers in the cervix completely eliminated both the lesion and the underlying HPV infection in a third of women enrolled in a clinical trial. "There ...
Cervical cancer continues to cause significant morbidity and mortality to women worldwide. As long as humans continue to have sex, people will continue to transmit human papillomavirus (HPV) from one ...
The Dynamic Spectral Imaging System (DYSIS) colposcope with DYSISmap and the ZedScan I adjunctive colposcopy technologies are intended to be used with colposcopy to help identify cervical ...
OSLO, Norway--(BUSINESS WIRE)--Vaccibody AS announced today vaccination of the first patient in its multicentre trial VB C-01 – an exploratory, open-label, multicenter phase I/IIa study VB10.16 ...
A potential new immune-based therapy to treat precancers in the cervix completely eliminated both the lesion and the underlying HPV infection in a third of women enrolled in a clinical trial. The shot ...
A new study takes several important steps toward being able to predict which HPV infections ultimately result in cervical cancer and which don’t, potentially paving the way to improved care or perhaps ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results